Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Gestational Diabetes App officially launched

Gestational Diabetes App officially launched

Innovation

A smartphone application for women with gestational diabetes, developed with support from NIHR Oxford Biomedical Research Centre, has been launched commercially.

New test successfully predicts all women who will not develop pre-eclampsia

New test successfully predicts all women who will not develop pre-eclampsia

Innovation Research

A new test that predicts with almost 100 per cent accuracy that a pregnant woman will not develop pre-eclampsia within the following seven days has been given the green light to be used as standard clinical practice in one of the UK’s biggest acute hospital trusts.

Gene therapy breakthrough in treating rare form of blindness

Gene therapy breakthrough in treating rare form of blindness

Innovation Research

Positive results of the world’s first gene therapy trial for a genetic cause of blindness known as choroideremia have been reported in Nature Medicine.

Oxford firm launches to predict and prevent heart attacks years before they happen

Oxford firm launches to predict and prevent heart attacks years before they happen

Innovation

Caristo Diagnostics, an Oxford University spinout company, has been launched to commercialise a new coronary CT image analysis technology that can flag patients at risk of deadly heart attacks years before they occur.

Regenerative medicine spinout OxStem launches subsidiaries

Regenerative medicine spinout OxStem launches subsidiaries

Innovation

Subsidiaries of the Oxford University spinout, OxStem Immuno and OxStem Beta, will draw on research from the institution.

Novo Nordisk Research Centre opens in Oxford

Novo Nordisk Research Centre opens in Oxford

General Innovation

The Rt Hon Greg Clark MP, Business, Energy and Industrial Strategy Secretary, has attended the inauguration of the Novo Nordisk Research Centre Oxford (NNRCO).

Showcase of Oxford’s leading role in AI healthcare revolution

Showcase of Oxford’s leading role in AI healthcare revolution

General Innovation

Oxford’s cutting-edge work in AI techniques that promise to transform healthcare has been showcased on BBC Radio 4’s Today programme.

Evox Therapeutics secures £35.5m Series B

Evox Therapeutics secures £35.5m Series B

General Innovation

The Oxford University spinout will use the investment to further develop its exosome technology, capable of delivering drugs to previously inaccessible parts of the body.

Partnership launched to develop cystic fibrosis gene therapy

Partnership launched to develop cystic fibrosis gene therapy

General Innovation

Experts at Oxford are teaming up with leading figures from industry to advance development of a gene therapy for cystic fibrosis.

Virtual reality used to treat fear of heights

Virtual reality used to treat fear of heights

Innovation Research

A study published in The Lancet Psychiatry provides first evidence that psychological therapy can be successfully delivered in virtual reality (VR).

Workshop helps Industry Fellows take drug from discovery to FDA approval - in four hours!

Workshop helps Industry Fellows take drug from discovery to FDA approval - in four hours!

General Innovation

Interactive workshop with Pfizer gives Oxford’s Industry Fellows the opportunity to put into action the Drug Discovery & Development Process

The One Show: SlowMo Story

The One Show: SlowMo Story

General Innovation

The app designed by researchers at the Department of Psychiatry to slow down negative thoughts of people with paranoia appeared on the BBC's The One Show. They revealed how one of the first users, Angie, is benefiting from this innovative approach.

First human test of robotic eye surgery a success

First human test of robotic eye surgery a success

Innovation Research

Researchers from the University of Oxford have completed the first successful trial of robot-assisted retinal surgery.

Rosalind Franklin Institute will 'transform' life sciences research through disruptive technologies

Rosalind Franklin Institute will 'transform' life sciences research through disruptive technologies

General Innovation

Business Secretary Greg Clark has today launched the £103m Rosalind Franklin Institute (RFI), a national centre of excellence that will harness disruptive technologies such as AI and robotics to improve dramatically our understanding of biology.

Body temperature liver storage technique improves transplant success

Body temperature liver storage technique improves transplant success

Innovation Research

Preserving livers at body temperature has been shown to improve transplant success and to increase the number of viable donor livers available for transplant, which could lead to shorter waiting lists for patients and lower mortality rates.

Oxford to benefit from government funding for research commercialisation

Oxford to benefit from government funding for research commercialisation

Innovation Research

Oxford is to take part in three new government-funded projects designed to help universities collaborate with each other, and with external organisations, to boost research commercialisation.

Oxford spinout Brainomix secures £7m investment to tackle strokes with AI

Oxford spinout Brainomix secures £7m investment to tackle strokes with AI

Innovation

Brainomix, a medical imaging company using artificial intelligence (AI) for the fast diagnosis and treatment of stroke victims, has attracted £7m ($9.8m) of investment to bring its software to the global healthcare market. The company was spun out from Oxford University research.

Computer simulations move step closer to reducing animal use in drug testing

Computer simulations move step closer to reducing animal use in drug testing

Innovation Research

The march towards replacing animals in drug testing with computer simulations has made another significant step forward, with the development of new software which can predict the possible cardiac side effects of taking a new drug.

Oxford 3D bio-printer company OxSyBio secures £10m Series A led by Woodford

Oxford 3D bio-printer company OxSyBio secures £10m Series A led by Woodford

Innovation

Woodford Investment Management leads round into OxSyBio, the second Oxford University spinout from Oxford Nanopore founder Hagan Bayley

Load More +